Today's paper — 5 reports, 29 minutes. Sign in once and every edition opens for you.
A Maharashtra Food and Drug Administration survey of hospital consumables has found an IV infusion set purchased at a trade price of ₹11.05 carrying a printed maximum retail price of ₹325, a markup of 2,841 per cent.
The survey covered syringes, catheters, oxygen masks, nebulisers and IV infusion sets used for patients admitted to private hospitals. A syringe procured at ₹6.75 carried an MRP of ₹57.20. A catheter bought at ₹29.41 carried an MRP of ₹310.
State FDA Commissioner Tukaram Mundhe submitted the findings to the Department of Pharmaceuticals and the National Pharmaceutical Pricing Authority in a communication dated 10 August, seeking a review and regulatory action. His proposals include capping trade margins, introducing structured price monitoring, setting clear guidelines on how large the gap between trade procurement price and declared MRP should be, and bringing essential categories of medical devices within an effective price-regulation framework.
5 reports filed for Wednesday 16 September 2026, compiled from company statements, registry filings and StartupFox reporting. Figures marked reported were not confirmed by the companies named.
A new edition is set whenever the desk files. The Newsroom is in beta — leave your email and we'll keep your seat.